Polymeric nanoparticles called Accurins reduce the toxicity of a group of anti-cancer drugs known as aurora kinase inhibitors. So say researchers at Bind Therapeutics and AstraZeneca, who have used the nanoparticle formulation to treat colorectal tumours in rats. The technology might be extended to other small-molecule anti-cancer drugs…….
http://nanotechweb.org/cws/article/tech/64049
